Hamlet Biopharma entered commercial collaborations with top international advisory firms to enhance partnering and strategic alliances. The collaboration has been initiated with the clinical stage oncology partnering asset with fast-track designation, Alpha1H.
A teaser describing the commercial approach is available below:
